本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Virpax Pharmaceuticals, Inc.

0.1665
-0.0115-6.46%
盘后0.1643-0.0022-1.32%19:58 EDT
成交量:145.57万
成交额:24.30万
市值:442.27万
市盈率:-0.01
高:0.1764
开:0.1710
低:0.1608
收:0.1780
数据加载中...

公司资料

公司名字:
Virpax Pharmaceuticals, Inc.
交易所:
NASDAQ
成立时间:
2016
员工人数:
2
公司地址:
1055 Westlakes Drive,Suite 300,Berwyn,Pennsylvania,United States
邮编:
19312
电话:
传真:
- -
简介:
Virpax Pharmaceuticals, Inc.于2017年5月12日在特拉华州注册成立。该公司是一家临床前阶段制药公司,专注于开发跨越各种疼痛适应症的新型专有给药系统,以增强依从性并优化每个在研产品候选者。该公司的药物输送系统和正在开发的药物释放技术专注于推进非阿片类药物和非成瘾性疼痛管理治疗和中枢神经系统(“CNS”)疾病的治疗,以提高患者的生活质量。

董事

名称
职位
Eric Floyd
Independent Chairman of the Board
Gerald Bruce
Chief Executive Officer and Director
Barbara A. Ruskin
Independent Director
Jeffrey Gudin
Executive Vice President, Chief Medical Officer and Director
Jerrold Sendrow
Independent Director
Michael F. Dubin
Independent Director
Thani Jambulingam
Independent Director
Vanila M. Singh
Independent Director

股东

名称
职位
Gerald Bruce
Chief Executive Officer and Director
Vinay Shah
Chief Financial Officer and Corporate Secretary
Jeffrey Gudin
Executive Vice President, Chief Medical Officer and Director
Sheila A. Mathias
Chief Scientific Officer